<div class="headers"><div>Figure 4. Mean HbA1c change from baseline at Week 24 by type of basal insulin (A), by age (B), and by renal impairment stage (C) (FAS; LOCF). eGFR, estimated glomerular filtration rate; FAS, full analysis set; HbA1c, glycated hemoglobin; LOCF, last observation carried forward; NPH, neutral protamine Hagedorn; qd, once daily.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">Figure 4. Mean HbA1c change from baseline at Week 24 by type of basal insulin (A), by age (B), and by renal impairment stage (C) (FAS; LOCF). eGFR, estimated glomerular filtration rate; FAS, full analysis set; HbA1c, glycated hemoglobin; LOCF, last observation carried forward; NPH, neutral protamine Hagedorn; qd, once daily.</p></td>
</tr>
</tbody>
</table>
